The SME IPO of Neochem Bio Solutions, which opened for subscription on Monday, December 2, 2025, on the NSE Emerge platform, has seen a slow start, recording a subscription of just 0.02 times by mid-morning on Day 1.
The IPO is commanding a grey market premium (GMP) of Rs 5, indicating a potential listing gain of approximately 5.1% over the upper price band of Rs 98 per share.
Neochem Bio Solutions is a specialty performance chemical manufacturer operating across four major segments: polymers, surfactants, silicones, and esters/biobased sustainable solutions.
The company operates a 22,000 MTPA manufacturing unit in Ahmedabad and is supported by a distribution network of over 50 distributors, serving 225+ domestic customers and exporting to 12 countries.
The net proceeds will be used to meet long-term working capital requirements, repay or prepay certain borrowings, and for general corporate purposes.
